back to cluster viewer
cluster path 001111100110100
128 words, 10,381 tokens
freq alpha suffix
Words in frequency order
1 | ph | 9,176
|
2 | pco2 | 211
|
3 | kt/v | 201
|
4 | po2 | 184
|
5 | impella | 79
|
6 | avds | 24
|
7 | 4× | 22
|
8 | biobanking | 19
|
9 | cτ | 17
|
10 | tamba | 17
|
11 | peak-flow | 15
|
12 | isthmuses | 14
|
13 | ppfd | 14
|
14 | mtab | 13
|
15 | ph-monitoring | 13
|
16 | bbos | 12
|
17 | clnp/bpo | 12
|
18 | hrts | 11
|
19 | mca-pi | 11
|
20 | edsbp | 9
|
21 | f-v | 9
|
22 | gtft | 9
|
23 | iadsbp | 8
|
24 | ttac | 8
|
25 | umf | 8
|
26 | 12rm | 7
|
27 | linbo | 7
|
28 | rung | 7
|
29 | dqc | 6
|
30 | lnh | 6
|
31 | c-protein | 5
|
32 | conveen | 5
|
33 | e/e-acr | 5
|
34 | eei | 5
|
35 | hematocrite | 5
|
36 | ncp4 | 5
|
37 | qrs-vd | 5
|
38 | re-turbt | 5
|
39 | si-oh | 5
|
40 | systat | 5
|
41 | 179mmhg | 4
|
42 | btsh | 4
|
43 | butb | 4
|
44 | carcinoma-in-situ | 4
|
45 | cc/aml | 4
|
46 | clindamycin-bpo | 4
|
47 | encore1 | 4
|
48 | gnasas | 4
|
49 | hc-ac | 4
|
50 | huh | 4
|
51 | index-level | 4
|
52 | s-gel | 4
|
53 | transplantectomy | 4
|
54 | ucem | 4
|
55 | y0 | 4
|
56 | 125i-radioactivity | 3
|
57 | cu-swt | 3
|
58 | dllme-sfo | 3
|
59 | gem2005 | 3
|
60 | lif-kf | 3
|
61 | mobic | 3
|
62 | nino | 3
|
63 | ph* | 3
|
64 | platelet-count | 3
|
65 | prosoy | 3
|
66 | time-to-death | 3
|
67 | zolpidem-er | 3
|
68 | φpma | 3
|
69 | 20/min | 2
|
70 | 3-mcg | 2
|
71 | 37.5- | 2
|
72 | 80/ | 2
|
73 | aes/patient-year | 2
|
74 | aetherolea | 2
|
75 | aminodat® | 2
|
76 | borkou | 2
|
77 | content- | 2
|
78 | digoxinemia | 2
|
79 | distillery | 2
|
80 | feto2 | 2
|
81 | hmt80 | 2
|
82 | id-mace | 2
|
83 | metastasectomies | 2
|
84 | mg/kg/cis | 2
|
85 | mixed-infections | 2
|
86 | ns2 | 2
|
87 | p3g | 2
|
88 | post-premedication | 2
|
89 | radon/thoron | 2
|
90 | sham-point | 2
|
91 | umd | 2
|
92 | 0.8155 | 1
|
93 | 2.5-high | 1
|
94 | 20q12-q13 | 1
|
95 | 3,5-dihydroxyhexanoic | 1
|
96 | 3,927 | 1
|
97 | 32.4+/- | 1
|
98 | 6.5-low | 1
|
99 | anabasine | 1
|
100 | aopwvest | 1
|
101 | arcmap | 1
|
102 | bioisoster | 1
|
103 | bladder/both | 1
|
104 | blood-ige | 1
|
105 | concentration-time-curve | 1
|
106 | deltapwv= | 1
|
107 | docetaxel+sunitinib | 1
|
108 | dose'of | 1
|
109 | dtpa-ph | 1
|
110 | follow-up-was | 1
|
111 | gly389gly | 1
|
112 | hyalift | 1
|
113 | hypoglycemia-glucose | 1
|
114 | hνprobe | 1
|
115 | least€71/heifer | 1
|
116 | mpd-group | 1
|
117 | multisim | 1
|
118 | omniview-sisporto | 1
|
119 | padj | 1
|
120 | pascorbin® | 1
|
121 | postlengthening | 1
|
122 | precast | 1
|
123 | psetta | 1
|
124 | ptcco2 | 1
|
125 | t1/t2* | 1
|
126 | ta606 | 1
|
127 | value-0-h | 1
|
128 | winnonlin® | 1
|
Words in alphabetical order
1 | 0.8155 | 1
|
2 | 125i-radioactivity | 3
|
3 | 12rm | 7
|
4 | 179mmhg | 4
|
5 | 2.5-high | 1
|
6 | 20/min | 2
|
7 | 20q12-q13 | 1
|
8 | 3,5-dihydroxyhexanoic | 1
|
9 | 3,927 | 1
|
10 | 3-mcg | 2
|
11 | 32.4+/- | 1
|
12 | 37.5- | 2
|
13 | 4× | 22
|
14 | 6.5-low | 1
|
15 | 80/ | 2
|
16 | aes/patient-year | 2
|
17 | aetherolea | 2
|
18 | aminodat® | 2
|
19 | anabasine | 1
|
20 | aopwvest | 1
|
21 | arcmap | 1
|
22 | avds | 24
|
23 | bbos | 12
|
24 | biobanking | 19
|
25 | bioisoster | 1
|
26 | bladder/both | 1
|
27 | blood-ige | 1
|
28 | borkou | 2
|
29 | btsh | 4
|
30 | butb | 4
|
31 | c-protein | 5
|
32 | carcinoma-in-situ | 4
|
33 | cc/aml | 4
|
34 | clindamycin-bpo | 4
|
35 | clnp/bpo | 12
|
36 | concentration-time-curve | 1
|
37 | content- | 2
|
38 | conveen | 5
|
39 | cu-swt | 3
|
40 | cτ | 17
|
41 | deltapwv= | 1
|
42 | digoxinemia | 2
|
43 | distillery | 2
|
44 | dllme-sfo | 3
|
45 | docetaxel+sunitinib | 1
|
46 | dose'of | 1
|
47 | dqc | 6
|
48 | dtpa-ph | 1
|
49 | e/e-acr | 5
|
50 | edsbp | 9
|
51 | eei | 5
|
52 | encore1 | 4
|
53 | f-v | 9
|
54 | feto2 | 2
|
55 | follow-up-was | 1
|
56 | gem2005 | 3
|
57 | gly389gly | 1
|
58 | gnasas | 4
|
59 | gtft | 9
|
60 | hc-ac | 4
|
61 | hematocrite | 5
|
62 | hmt80 | 2
|
63 | hrts | 11
|
64 | huh | 4
|
65 | hyalift | 1
|
66 | hypoglycemia-glucose | 1
|
67 | hνprobe | 1
|
68 | iadsbp | 8
|
69 | id-mace | 2
|
70 | impella | 79
|
71 | index-level | 4
|
72 | isthmuses | 14
|
73 | kt/v | 201
|
74 | least€71/heifer | 1
|
75 | lif-kf | 3
|
76 | linbo | 7
|
77 | lnh | 6
|
78 | mca-pi | 11
|
79 | metastasectomies | 2
|
80 | mg/kg/cis | 2
|
81 | mixed-infections | 2
|
82 | mobic | 3
|
83 | mpd-group | 1
|
84 | mtab | 13
|
85 | multisim | 1
|
86 | ncp4 | 5
|
87 | nino | 3
|
88 | ns2 | 2
|
89 | omniview-sisporto | 1
|
90 | p3g | 2
|
91 | padj | 1
|
92 | pascorbin® | 1
|
93 | pco2 | 211
|
94 | peak-flow | 15
|
95 | ph | 9,176
|
96 | ph* | 3
|
97 | ph-monitoring | 13
|
98 | platelet-count | 3
|
99 | po2 | 184
|
100 | post-premedication | 2
|
101 | postlengthening | 1
|
102 | ppfd | 14
|
103 | precast | 1
|
104 | prosoy | 3
|
105 | psetta | 1
|
106 | ptcco2 | 1
|
107 | qrs-vd | 5
|
108 | radon/thoron | 2
|
109 | re-turbt | 5
|
110 | rung | 7
|
111 | s-gel | 4
|
112 | sham-point | 2
|
113 | si-oh | 5
|
114 | systat | 5
|
115 | t1/t2* | 1
|
116 | ta606 | 1
|
117 | tamba | 17
|
118 | time-to-death | 3
|
119 | transplantectomy | 4
|
120 | ttac | 8
|
121 | ucem | 4
|
122 | umd | 2
|
123 | umf | 8
|
124 | value-0-h | 1
|
125 | winnonlin® | 1
|
126 | y0 | 4
|
127 | zolpidem-er | 3
|
128 | φpma | 3
|
Words in suffix order
1 | t1/t2* | 1
|
2 | ph* | 3
|
3 | 32.4+/- | 1
|
4 | 37.5- | 2
|
5 | content- | 2
|
6 | 80/ | 2
|
7 | hmt80 | 2
|
8 | y0 | 4
|
9 | encore1 | 4
|
10 | ptcco2 | 1
|
11 | pco2 | 211
|
12 | po2 | 184
|
13 | feto2 | 2
|
14 | ns2 | 2
|
15 | 20q12-q13 | 1
|
16 | ncp4 | 5
|
17 | gem2005 | 3
|
18 | 0.8155 | 1
|
19 | ta606 | 1
|
20 | 3,927 | 1
|
21 | deltapwv= | 1
|
22 | tamba | 17
|
23 | aetherolea | 2
|
24 | digoxinemia | 2
|
25 | impella | 79
|
26 | φpma | 3
|
27 | psetta | 1
|
28 | mtab | 13
|
29 | docetaxel+sunitinib | 1
|
30 | butb | 4
|
31 | hc-ac | 4
|
32 | ttac | 8
|
33 | mobic | 3
|
34 | 3,5-dihydroxyhexanoic | 1
|
35 | dqc | 6
|
36 | ppfd | 14
|
37 | umd | 2
|
38 | qrs-vd | 5
|
39 | hνprobe | 1
|
40 | id-mace | 2
|
41 | blood-ige | 1
|
42 | anabasine | 1
|
43 | hypoglycemia-glucose | 1
|
44 | hematocrite | 5
|
45 | concentration-time-curve | 1
|
46 | lif-kf | 3
|
47 | umf | 8
|
48 | dose'of | 1
|
49 | p3g | 2
|
50 | 3-mcg | 2
|
51 | 179mmhg | 4
|
52 | biobanking | 19
|
53 | postlengthening | 1
|
54 | ph-monitoring | 13
|
55 | rung | 7
|
56 | value-0-h | 1
|
57 | 2.5-high | 1
|
58 | lnh | 6
|
59 | si-oh | 5
|
60 | ph | 9,176
|
61 | dtpa-ph | 1
|
62 | btsh | 4
|
63 | time-to-death | 3
|
64 | bladder/both | 1
|
65 | huh | 4
|
66 | eei | 5
|
67 | mca-pi | 11
|
68 | padj | 1
|
69 | s-gel | 4
|
70 | index-level | 4
|
71 | cc/aml | 4
|
72 | ucem | 4
|
73 | multisim | 1
|
74 | 12rm | 7
|
75 | conveen | 5
|
76 | c-protein | 5
|
77 | 20/min | 2
|
78 | post-premedication | 2
|
79 | radon/thoron | 2
|
80 | linbo | 7
|
81 | dllme-sfo | 3
|
82 | nino | 3
|
83 | clindamycin-bpo | 4
|
84 | clnp/bpo | 12
|
85 | omniview-sisporto | 1
|
86 | arcmap | 1
|
87 | iadsbp | 8
|
88 | edsbp | 9
|
89 | mpd-group | 1
|
90 | aes/patient-year | 2
|
91 | e/e-acr | 5
|
92 | zolpidem-er | 3
|
93 | least€71/heifer | 1
|
94 | bioisoster | 1
|
95 | gnasas | 4
|
96 | follow-up-was | 1
|
97 | avds | 24
|
98 | metastasectomies | 2
|
99 | isthmuses | 14
|
100 | mg/kg/cis | 2
|
101 | mixed-infections | 2
|
102 | bbos | 12
|
103 | hrts | 11
|
104 | systat | 5
|
105 | re-turbt | 5
|
106 | hyalift | 1
|
107 | gtft | 9
|
108 | sham-point | 2
|
109 | platelet-count | 3
|
110 | precast | 1
|
111 | aopwvest | 1
|
112 | cu-swt | 3
|
113 | borkou | 2
|
114 | carcinoma-in-situ | 4
|
115 | f-v | 9
|
116 | kt/v | 201
|
117 | 6.5-low | 1
|
118 | peak-flow | 15
|
119 | gly389gly | 1
|
120 | transplantectomy | 4
|
121 | prosoy | 3
|
122 | distillery | 2
|
123 | 125i-radioactivity | 3
|
124 | cτ | 17
|
125 | 4× | 22
|
126 | pascorbin® | 1
|
127 | winnonlin® | 1
|
128 | aminodat® | 2
|